PETER MUELLER - 09 Jan 2026 Form 4 Insider Report for BioXcel Therapeutics, Inc. (BTAI)

Role: Director
Signature: /s/ Richard Steinhart, Attorney-in-Fact for Peter Mueller
Issuer symbol: BTAI
Transactions as of: 09 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 12 Jan 2026, 19:06:49 UTC
Previous filing: 11 Jun 2024
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
MUELLER PETER	Director	C/O BIOXCEL THERAPEUTICS, INC., 555 LONG WHARF DRIVE, 12TH FLOOR, NEW HAVEN	/s/ Richard Steinhart, Attorney-in-Fact for Peter Mueller	12 Jan 2026	0001256126

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BTAI	Stock Option (Right to Buy)	Award	$0	+17,000		$0.000000	17,000	09 Jan 2026	Common Stock	17,000	$2.01	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date.